Some interesting questions posed, issues highlighted and discussions had.
Read all the takeaways at these two links.
https://businessofcannabis.com/cannabis-health-symposium-2025-key-takeaways-part-1/
https://businessofcannabis.com/cannabis-health-symposium-2025-key-takeaways-part-2/
For me the question is what advantages in the market are Curaleaf looking to attain.
The content of the event suggests a desire for Curaleaf to have the following
A) Access to NHS decision makers
B) A major place in the ecosystem of UK medical cannabis health education and i note that unsurprisingly a continuing education modus operandi in the UK health system is suggested with Curaleaf central in the provision of knowledge.
Is this a good idea?
Most likely not.
